Best Monoamine Oxidase Inhibitor for parkinson disease
3 Monoamine Oxidase Inhibitor drugs indicated for parkinson disease, ranked by our independent rating. The current highest-rated is azilect. Compare them with all treatments for parkinson disease or the full Monoamine Oxidase Inhibitor class. Not medical advice — always consult a professional.
Top monoamine oxidase inhibitor for parkinson disease: 1. Azilect · 2. Emsam · 3. Zelapar
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Azilect | 46/100 | Prescription | $33 | View → |
| 2 | Emsam | Not yet rated | Prescription | $19 | View → |
| 3 | Zelapar | Not yet rated | Prescription |
Full ranking · 3 drugs
Frequently asked
- What is the best monoamine oxidase inhibitor for parkinson disease?
- By our independent rating, azilect currently ranks highest among Monoamine Oxidase Inhibitor drugs used for parkinson disease. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which monoamine oxidase inhibitor drugs treat parkinson disease?
- pharmaranks lists 3 Monoamine Oxidase Inhibitor products indicated for parkinson disease, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.